PL3100725T3 - Środek wzmacniający efekt rehabilitacji po uszkodzeniu nerwu zawierający pochodną eteru alkilowego lub jej sól - Google Patents

Środek wzmacniający efekt rehabilitacji po uszkodzeniu nerwu zawierający pochodną eteru alkilowego lub jej sól

Info

Publication number
PL3100725T3
PL3100725T3 PL15743367T PL15743367T PL3100725T3 PL 3100725 T3 PL3100725 T3 PL 3100725T3 PL 15743367 T PL15743367 T PL 15743367T PL 15743367 T PL15743367 T PL 15743367T PL 3100725 T3 PL3100725 T3 PL 3100725T3
Authority
PL
Poland
Prior art keywords
salt
alkyl ether
enhancing agent
nerve injury
ether derivative
Prior art date
Application number
PL15743367T
Other languages
English (en)
Inventor
Takuya Takahashi
Tomohiro Okuda
Original Assignee
Fujifilm Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Toyama Chemical Co., Ltd. filed Critical Fujifilm Toyama Chemical Co., Ltd.
Publication of PL3100725T3 publication Critical patent/PL3100725T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15743367T 2014-01-31 2015-01-30 Środek wzmacniający efekt rehabilitacji po uszkodzeniu nerwu zawierający pochodną eteru alkilowego lub jej sól PL3100725T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014017587 2014-01-31
PCT/JP2015/052617 WO2015115582A1 (ja) 2014-01-31 2015-01-30 アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤
EP15743367.3A EP3100725B1 (en) 2014-01-31 2015-01-30 Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof

Publications (1)

Publication Number Publication Date
PL3100725T3 true PL3100725T3 (pl) 2020-11-16

Family

ID=53757150

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15743367T PL3100725T3 (pl) 2014-01-31 2015-01-30 Środek wzmacniający efekt rehabilitacji po uszkodzeniu nerwu zawierający pochodną eteru alkilowego lub jej sól

Country Status (26)

Country Link
US (2) US10039744B2 (pl)
EP (1) EP3100725B1 (pl)
JP (3) JP5837726B1 (pl)
KR (1) KR102346219B1 (pl)
CN (1) CN106061478B (pl)
AU (1) AU2015211753B2 (pl)
BR (1) BR112016017747A2 (pl)
CA (1) CA2938184C (pl)
CY (1) CY1123154T1 (pl)
DK (1) DK3100725T3 (pl)
ES (1) ES2792950T3 (pl)
HR (1) HRP20200796T1 (pl)
HU (1) HUE050400T2 (pl)
IL (1) IL246925B (pl)
LT (1) LT3100725T (pl)
MX (1) MX2016009751A (pl)
MY (1) MY179290A (pl)
PH (1) PH12016501507A1 (pl)
PL (1) PL3100725T3 (pl)
PT (1) PT3100725T (pl)
RS (1) RS60462B1 (pl)
RU (1) RU2680247C2 (pl)
SG (2) SG11201606173TA (pl)
SI (1) SI3100725T1 (pl)
SM (1) SMT202000395T1 (pl)
WO (1) WO2015115582A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016017747A2 (pt) * 2014-01-31 2017-08-08 Toyama Chemical Co Ltd Agente de intensificação de efeito de reabilitação pós lesão de nervo compreendendo derivados de éter de alquila ou sal do mesmo
CA3009152C (en) 2015-12-25 2023-08-15 Toyama Chemical Co., Ltd. Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
JP7057286B2 (ja) * 2016-12-28 2022-04-19 富士フイルム富山化学株式会社 医薬組成物
CN110121342A (zh) * 2016-12-28 2019-08-13 富士胶片富山化学株式会社 医药组合物
US20190343796A1 (en) * 2016-12-28 2019-11-14 Fujifilm Toyama Chemical Co., Ltd. Composition for external use
US11234962B2 (en) 2016-12-28 2022-02-01 Fujifilm Toyama Chemical Co., Ltd. Pharmaceutical composition and method of manufacturing the same
CA3067455C (en) * 2017-06-02 2021-11-23 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating spinocerebellar ataxia
JP7370859B2 (ja) * 2017-06-02 2023-10-30 富士フイルム富山化学株式会社 タウオパチー予防または治療剤
KR20190137936A (ko) * 2017-06-02 2019-12-11 후지필름 도야마 케미컬 가부시키가이샤 뇌 위축 예방 또는 치료제
US11541033B2 (en) 2017-06-02 2023-01-03 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating Alzheimer's disease
MX393006B (es) * 2017-06-02 2025-03-24 Fujifilm Toyama Chemical Co Ltd Agente para reducir la cantidad de proteina beta amiloide.
JP7227914B2 (ja) 2017-10-30 2023-02-22 富士フイルム富山化学株式会社 エモパミル結合タンパク質結合剤およびその利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0213393B8 (pt) * 2001-10-19 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica
WO2003045137A1 (fr) * 2001-11-29 2003-06-05 Japan Science And Technology Agency Procede de construction d'un modele simien de lesion spinale et son utilisation
HUE041842T2 (hu) 2002-06-14 2019-05-28 Toyama Chemical Co Ltd Gyógyászati készítmény agymûködés javítására
ES2391273T3 (es) 2003-04-17 2012-11-23 Toyama Chemical Co., Ltd. Agente preventivo/curativo para enfermedades del nervio retiniano que contiene derivados de éter alquílico o sus sales
SI2248809T1 (sl) 2005-03-28 2012-09-28 Toyama Chemical Co Ltd Alkil-3-(2-(benzo(b)tiofen-5-il)-etoksi)-propanoati kot vmesniki v proizvodnji derivatov azetidin-3-ola
RU2397169C2 (ru) * 2005-03-28 2010-08-20 Тояма Кемикал Ко., Лтд. Способ получения 1-(3-(2-(1-бензотиофен-5-ил)этокси) пропил)азетидин-3-ола или его солей
CA2648898C (en) * 2006-04-26 2015-01-20 Toyama Chemical Co., Ltd. Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
US8119625B2 (en) * 2006-04-26 2012-02-21 Toyama Chemical Co., Ltd. Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
BR112016017747A2 (pt) * 2014-01-31 2017-08-08 Toyama Chemical Co Ltd Agente de intensificação de efeito de reabilitação pós lesão de nervo compreendendo derivados de éter de alquila ou sal do mesmo

Also Published As

Publication number Publication date
JP6642914B2 (ja) 2020-02-12
NZ722542A (en) 2021-07-30
PH12016501507A1 (en) 2017-02-06
RU2016135236A (ru) 2018-03-02
HK1226298A1 (en) 2017-09-29
AU2015211753B2 (en) 2019-09-12
CA2938184A1 (en) 2015-08-06
SI3100725T1 (sl) 2020-08-31
US20180289668A1 (en) 2018-10-11
SMT202000395T1 (it) 2020-09-10
US10039744B2 (en) 2018-08-07
JP5837726B1 (ja) 2015-12-24
JP2016074676A (ja) 2016-05-12
EP3100725B1 (en) 2020-05-06
DK3100725T3 (da) 2020-06-22
IL246925A0 (en) 2016-09-29
RS60462B1 (sr) 2020-07-31
MY179290A (en) 2020-11-03
CA2938184C (en) 2021-11-23
JPWO2015115582A1 (ja) 2017-03-23
CY1123154T1 (el) 2021-10-29
MX2016009751A (es) 2016-11-08
RU2016135236A3 (pl) 2018-08-30
SG11201606173TA (en) 2016-08-30
HRP20200796T1 (hr) 2020-08-07
KR102346219B1 (ko) 2022-01-04
US20170165227A1 (en) 2017-06-15
IL246925B (en) 2019-10-31
WO2015115582A1 (ja) 2015-08-06
JP2020073542A (ja) 2020-05-14
HUE050400T2 (hu) 2020-12-28
AU2015211753A1 (en) 2016-08-11
EP3100725A1 (en) 2016-12-07
RU2680247C2 (ru) 2019-02-19
EP3100725A4 (en) 2017-08-30
PT3100725T (pt) 2020-06-17
BR112016017747A2 (pt) 2017-08-08
CN106061478B (zh) 2019-04-30
ES2792950T3 (es) 2020-11-12
LT3100725T (lt) 2020-08-10
SG10201907035TA (en) 2019-09-27
CN106061478A (zh) 2016-10-26
US10471044B2 (en) 2019-11-12
KR20160113281A (ko) 2016-09-28
JP6825074B2 (ja) 2021-02-03

Similar Documents

Publication Publication Date Title
LT3100725T (lt) Reabilitacijos poveikį po nervo pažeidimo sustiprinanti priemonė, apimanti alkileterio darinį arba jo druską
GB201809461D0 (en) Leg movement stimulator device
ZA201607866B (en) Solid-stabilized emulsion
DK3233221T3 (da) Træningsindretning
IL249356B (en) A derivative of 2-acylaminothiazole or its salt
FI20145222A7 (fi) Nyrkkeilyharjoitteluapuväline
PL3018257T3 (pl) Słupek bariery
EP3380137C0 (en) AUTOMATIC INJECTOR DEVICE
SG11201607387PA (en) Implement for training facial muscle
PL3085227T3 (pl) Trenażer ruchu dla małych zwierząt
GB201608979D0 (en) Intraosseous infusion training system
GB2526178B (en) Horse-riding training device
GB2522427B (en) A training device
GB2532578B (en) Animal amusement device
GB201405348D0 (en) Training cassette for auto-injector
TWM490333U (en) Weight training machine
GB2522069B (en) Bird guard device
GB2550133B (en) Training Device
GB2524086B (en) A deterrent device
GB201402820D0 (en) Fence attachment device
GB2546148B (en) Animal deterrent
ZA201705079B (en) Deterrent device
GB201615786D0 (en) Animal training aid
GB201516639D0 (en) Attachment for boxing training devices
GB201415801D0 (en) Cat Fight Deterrent Colar